Inhibition of chemical carcinogen-induced neoplasia by coumarins and alpha-angelicalactone.
D015107:4-Butyrolactone / Q000031:analogs & derivatives; D015127:9,10-Dimethyl-1,2-benzanthracene / Q000037:antagonists & inhibitors; D000818:Animals; D001580:Benzopyrenes / Q000037:antagonists & inhibitors; D003374:Coumarins / Q000494:pharmacology*; D005260:Female; D005663:Furans / Q000494:pharmacology*; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D051379:Mice; D008813:Mice, Inbred ICR; D009374:Neoplasms, Experimental / Q000517:prevention & control; D051381:Rats; D013274:Stomach Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D013329:Structure-Activity Relationship
D001580:Benzopyrenes; D003374:Coumarins; D005663:Furans; C019257:angelica lactone; D015127:9,10-Dimethyl-1,2-benzanthracene; D015107:4-Butyrolactone